Vertigo, a common yet complex clinical challenge, is characterized by the sensation of spinning or movement, often associated with nausea, vomiting, and balance disorders. It is frequently encountered in primary care and emergency departments, requiring a comprehensive clinical approach for effective management.
Vertigo may originate from peripheral or central vestibular systems. Peripheral vertigo, the most common type, is usually due to benign paroxysmal positional vertigo (BPPV), Meniere's disease, or vestibular neuritis. Central vertigo, though less common, can be a sign of serious conditions such as stroke or multiple sclerosis.
A thorough history and physical examination are key to diagnosing vertigo. The Dix-Hallpike maneuver and the head impulse test can help differentiate peripheral from central causes. Additionally, understanding the onset, duration, and associated symptoms can guide further investigations.
Management typically involves treating the underlying cause and symptomatic relief. For BPPV, canalith repositioning maneuvers like the Epley maneuver are effective. Pharmacotherapy, including antihistamines and benzodiazepines, can provide symptomatic relief. In central vertigo, addressing the underlying neurologic disorder is crucial.
Vestibular rehabilitation therapy (VRT) is an integral part of managing chronic vertigo. It includes exercises that promote central nervous system compensation for inner ear deficits. VRT can significantly improve quality of life in patients with persistent vertigo.
Vertigo presents unique diagnostic and therapeutic challenges. A systematic approach, including a detailed history, physical examination, and appropriate diagnostic tests, is vital for accurate diagnosis and effective treatment. Understanding the pathophysiology, clinical features, and management strategies can enhance patient care and outcomes in this common clinical scenario.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation